Immunosuppressant FK506 Activates NF-κB through the Proteasome-mediated Degradation of IκBα
Open Access
- 1 December 1999
- journal article
- Published by Elsevier BV
- Vol. 274 (49), 34657-34662
- https://doi.org/10.1074/jbc.274.49.34657
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinasesInternational Immunology, 1999
- Signal transduction through NF-κBImmunology Today, 1998
- IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB ActivationScience, 1997
- The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB ActivationCell, 1997
- Identification and Characterization of an IκB KinaseCell, 1997
- Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin in Cultured CellsJournal of Biological Chemistry, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Ubiquitinylation Is Not an Absolute Requirement for Degradation of c-Jun Protein by the 26 S ProteasomePublished by Elsevier BV ,1995
- The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.The Journal of Experimental Medicine, 1992
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992